Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases.
作者信息
Long W K, Wilson S W, Frenkel E P
出版信息
Am J Hum Genet. 1967 Jan;19(1):35-53.
Abstract
摘要
相似文献
1
Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases.红细胞葡萄糖-6-磷酸脱氢酶变异体与血管疾病之间的关联。
Am J Hum Genet. 1967 Jan;19(1):35-53.
2
New variants of glucose-6-phosphate dehydrogenase: G6PD Kilgore and G6PD Galveston.葡萄糖-6-磷酸脱氢酶的新变体：G6PD基尔戈变体和G6PD加尔维斯顿变体。
Tex Rep Biol Med. 1973 Winter;31(4):727-44.
3
Red cell glucose-6-phosphate dehydrogenase deficiency in Finland.芬兰的红细胞葡萄糖-6-磷酸脱氢酶缺乏症
Ann Clin Res. 1973 Jun;5(3):168-73.
4
Double heterozygosity for glucose-6-phosphate dehydrogenase deficiency.葡萄糖-6-磷酸脱氢酶缺乏症的双重杂合性
J Med Genet. 1971 Jun;8(2):149-52. doi: 10.1136/jmg.8.2.149.
5
Family investigations of erythrocyte glucose-6-phosphate dehydrogenase in favism.蚕豆病中红细胞葡萄糖-6-磷酸脱氢酶的家系调查
Pol Med J. 1970;9(5):1093-9.
6
Electrophoretic characterisation of glucose-6-phosphate dehydrogenase in Ghana.加纳葡萄糖-6-磷酸脱氢酶的电泳特性分析
Lancet. 1972 Jul 1;2(7766):44. doi: 10.1016/s0140-6736(72)91301-3.
7
Clinical and biochemical interactions of glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.葡萄糖-6-磷酸脱氢酶缺乏症与镰状细胞贫血的临床及生化相互作用。
N Engl J Med. 1972 Aug 3;287(5):213-7. doi: 10.1056/NEJM197208032870502.
8
[Immunologic determination of glucose-6-phosphate dehydrogenase concentration of red blood cells of G6PD defect carriers].
Z Med Lab Diagn. 1985;26(4):213-20.
9
Genetic markers and anthropometry in the populations of the Egyptian oases of El-Kharga and El-Dakhla.
Hum Hered. 1974;24(3):259-72. doi: 10.1159/000152659.
10
Heterogeneity of red cell glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in Egypt.埃及红细胞葡萄糖-6-磷酸脱氢酶（G-6-PD）缺乏症的异质性。
J Lab Clin Med. 1974 Nov;84(5):673-80.
引用本文的文献
1
Clinical associations and potential cellular mechanisms linking G6PD deficiency and atherosclerotic cardiovascular disease.将葡萄糖-6-磷酸脱氢酶缺乏症与动脉粥样硬化性心血管疾病联系起来的临床关联及潜在细胞机制。
NPJ Metab Health Dis. 2025;3(1):16. doi: 10.1038/s44324-025-00061-6. Epub 2025 Apr 24.
2
Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease.变异增加了血管内皮生长因子受体阻滞剂引起的肺血管疾病的发病风险。
J Am Heart Assoc. 2024 Oct;13(19):e035174. doi: 10.1161/JAHA.123.035174. Epub 2024 Sep 18.
3
Mediterranean G6PD variant rats are protected from Angiotensin II-induced hypertension and kidney damage, but not from inflammation and arterial stiffness.地中海 G6PD 变异大鼠可以预防血管紧张素 II 诱导的高血压和肾脏损伤，但不能预防炎症和动脉僵硬。
Vascul Pharmacol. 2022 Aug;145:107002. doi: 10.1016/j.vph.2022.107002. Epub 2022 May 24.
4
Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.靶向治疗心力衰竭的代谢疗法中的肾上腺素能受体。
Int J Mol Sci. 2021 May 28;22(11):5783. doi: 10.3390/ijms22115783.
5
The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review.葡萄糖-6-磷酸脱氢酶缺乏症在心血管疾病中的争议角色：一项叙事性综述。
Oxid Med Cell Longev. 2021 Apr 29;2021:5529256. doi: 10.1155/2021/5529256. eCollection 2021.
6
CRISPR-Mediated Single Nucleotide Polymorphism Modeling in Rats Reveals Insight Into Reduced Cardiovascular Risk Associated With Mediterranean Variant.CRISPR 介导的大鼠单核苷酸多态性建模揭示了与地中海变体相关的心血管疾病风险降低的机制。
Hypertension. 2020 Aug;76(2):523-532. doi: 10.1161/HYPERTENSIONAHA.120.14772. Epub 2020 Jun 8.
7
DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice.葡萄糖-6-磷酸脱氢酶缺乏小鼠的 DNA 损伤、突触和行为障碍。
Redox Biol. 2020 Jan;28:101332. doi: 10.1016/j.redox.2019.101332. Epub 2019 Sep 18.
8
Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers.葡萄糖-6-磷酸脱氢酶缺乏症与美国军事中心的心血管疾病有关。
Tex Heart Inst J. 2018 Jun 1;45(3):144-150. doi: 10.14503/THIJ-16-6052. eCollection 2018 Jun.
9
Healing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.治愈孤独之心：葡萄糖-6-磷酸脱氢酶缺乏症患者的心力衰竭
BMJ Case Rep. 2015 Mar 5;2015:bcr2015209365. doi: 10.1136/bcr-2015-209365.
10
Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.SIRT2 和 KAT9 通过调节 G6PD 的乙酰化来调节氧化应激过程中的 NADPH 稳态和细胞存活。
EMBO J. 2014 Jun 17;33(12):1304-20. doi: 10.1002/embj.201387224. Epub 2014 Apr 25.
本文引用的文献
1
Significance of endogenous cholesterol in arteriosclerosis; synthesis in arterial tissue.内源性胆固醇在动脉硬化中的意义；在动脉组织中的合成。
Science. 1951 Jun 29;113(2948):747-9. doi: 10.1126/science.113.2948.747.
2
Atherosclejosis in the Bantu. The distribution of atheromatous lesions in Africans over 50 years of age.班图人的动脉粥样硬化。50岁以上非洲人的动脉粥样硬化病变分布情况。
Circulation. 1962 Jan;25:66-72. doi: 10.1161/01.cir.25.1.66.
3
Mortality statistics in Israel. A survey of the years 1950-1960.
Isr Med J. 1962 Jan-Feb;21:1-11.
4
A review of cardiovascular diseases in the white and Negro races.白种人和黑种人心血管疾病综述。
Medicine (Baltimore). 1960 May;39:241-88. doi: 10.1097/00005792-196005000-00003.
5
CERTAIN METABOLIC PATTERNS OF ATHEROMATOUS PIGEON AORTAS.动脉粥样硬化鸽主动脉的某些代谢模式
Arch Pathol. 1965 Sep;80:291-6.
6
DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE ELECTROPHORETIC VARIANTS IN DIFFERENT TISSUES OF HETEROZYGOTES.葡萄糖-6-磷酸脱氢酶电泳变异体在杂合子不同组织中的分布
Am J Hum Genet. 1965 May;17(3):212-20.
7
CORONARY HEART DISEASE AMONG NEGROES AND WHITES IN EVANS COUNTY, GEORGIA.佐治亚州埃文斯县黑人和白人中的冠心病情况
J Chronic Dis. 1965 May;18:443-68.
8
FUNCTIONALLY ABNORMAL GLUCOSE-6-PHOSPHATE DEHYDROGENASES.功能异常的葡萄糖-6-磷酸脱氢酶
Cold Spring Harb Symp Quant Biol. 1964;29:391-8. doi: 10.1101/sqb.1964.029.01.041.
9
MYOCARDIOPATHY IN ARGEMONE MEXICANA POISONING.
S Afr Med J. 1965 Feb 6;39:108-14.
10
ELECTROPHORETICALLY SLOW VARIANTS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FROM RED CELLS OF NEGROES.
J Lab Clin Med. 1965 Jan;65:81-7.
Zotero 插件